Global Overview – Requirements Necessary to Assure the Best Possible Management and Maintenance of Global Submissions
Sep 19 2013 11:00AM - Sep 19 2013 12:30PM | Online
This webinar will be broadcast in Eastern Daylight Time (EDT)
The aim of this session is to provide attendees with a high level overview of the kinds of tools and information that are required in order to keep up with regulatory updates. At the end of this session, the attendees will have a better idea of the variety of options to them to ensure compliance with global regulations.
Who Should Attend
Professionals with intermediate to advanced knowledge of, and experience in:
- Global Regulatory Submissions
At the conclusion of this webinar, participants should be able to:
- Discuss the variety of options available to ensure compliance with global regulations.
- Describe the best possible management of global submissions
for minimum system requirements.
Drug Information Association has been accredited as an Authorized Provider by the International Association for Continuing Education and Training (IACET), 1760 Old Meadow Road, Suite 500, McLean, VA 22102.
As an IACET Authorized Provider, Drug Information Association offers CEUs for its programs that qualify under the ANSI/IACET Standard. Drug Information Association is authorized by IACET to offer.1 CEUs for this program. Participants must attend the entire program in order to be able to receive an IACET statement of credit. No partial credit will be awarded.
DIA’s Certificate Program Statement
This program is part of DIA’s Certificate Program and is awarded the following:
• Regulatory Affairs Certificate Program: 1 Elective Units
For more information go to www.diahome.org/certificateprograms
|Global Overview – Requirements Necessary
It is DIA policy that anyone in a position to control the content of a continuing education activity must disclose to the program audience (1) any real or apparent conflict(s) of interest related to the content of their presentation and/or the educational activity, and (2) discussions of unlabeled or unapproved uses of drugs or medical devices. Disclosure statements will be included in the course materials.
Statement of Credit:
If you would like to receive a statement of credit, you must participate in the live webinar & complete the online credit request process through My Transcript. To access My Transcript, please go to www.diahome.org, select “Login to My DIA” & you will be prompted for your user ID & password. Select “My Transcript” (left side bar) & “Credit Request” to process your credit request. Participants will be able to download a statement of credit upon successful submission of the credit request. My Transcript will be available for credit requests on October 3, 2013.
Continuing education credits and Certificate Program units are available to learners who participate in the live webinar. Continuing Education credits and Certificate Program units are not available for participation in the archived version of the webinar.
To view DIA’s grievance policy, please visit the CE page on the DIA website at www.diahome.org/CE
- Government (Full Time) Individual
- Charitable Nonprofit/Academia Individual
- Group Site
- Group Plus
- Member Industry Individual
- NonMember Industry Individual
- Group site registration is a license for ONE internet login allowing multiple viewers from one location.
- Group Plus is a license for up to FIVE internet logins allowing one or more viewers at each login location.
No refunds will be provided in the event of a participant’s cancellation since all costs for this webinar have been prepaid by DIA. DIA reserves the right to modify or cancel programs and/or substitute presenters or panelists. DIA is not responsible for failure to deliver programs due to circumstances beyond its control.
Participants with Disabilities: Reasonable accommodations will be made available to persons with disabilities who attend an educational activity. Contact the DIA office in writing at least 15 days prior to event to indicate your needs.
Unless otherwise disclosed, the statements made by speakers represent their own opinions and not necessarily those of the organization they represent, or that of the Drug Information Association. Speakers, agenda and CE information are subject to change without notice. Recording of any DIA educational material in any type of media is prohibited without prior written consent from DIA.